Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.5 to v3.6.6, signaling a new build of the page. This represents minor metadata or UI changes rather than substantive changes to study data.
    Difference
    0.1%
    Check dated 2026-08-30T21:38:58.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The release notes footer now shows Revision: v3.6.5, replacing v3.6.4, indicating a small build update. This change does not alter the study details or how the page functions.
    Difference
    0.1%
    Check dated 2026-08-09T08:22:56.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-07-25T18:24:00.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a minor system update. No study content or key information appears to be altered.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:54.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision upgraded from v3.6.0 to v3.6.2, indicating a newer build of the page. No study-related content or functionality appears to be altered by this update.
    Difference
    0.1%
    Check dated 2026-06-27T03:58:31.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The page now includes a recruitment status notice indicating no further participant recruitment, and adds helpful guidance links such as How to Read a Study Record, Common Questions, and How to Join a Study. Additionally, the Intervention/Treatment label formatting is adjusted and the site revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T22:11:45.000Z thumbnail image

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.